[1]
VERMA, V. et al. 2021. PROFILE OF SURROGATE MARKERS OF MOLECULAR SUBTYPES USING THE EXPRESSION PATTERN OF ER, PR, AND HER2/NEU RECEPTORS IN OPERABLE BREAST CANCER. Asian Journal of Pharmaceutical and Clinical Research. 14, 9 (Sep. 2021), 149–152. DOI:https://doi.org/10.22159/ajpcr.2021.v14i9.42526.